Royalty Pharma
RPRX
#624
Rank
A$58.46 B
Marketcap
A$101.68
Share price
-1.22%
Change (1 day)
67.72%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: A$58.46 Billion

As of November 2026 Royalty Pharma has a market cap of A$58.46 Billion. This makes Royalty Pharma the world's 624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$58.46 B71.21%
2025A$34.14 B41.15%
2024A$24.19 B-2.14%
2023A$24.72 B-3.5%
2022A$25.61 B8.51%
2021A$23.60 B-6.55%
2020A$25.26 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Royalty Pharma was reported to be:

A$59.04 Billion
by Nasdaq info icon info icon
A$59.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
A$269.34 B 360.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.805 T 2,988.06%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$2.35 B-95.98%๐Ÿ‡บ๐Ÿ‡ธ USA